Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia.

Bioorg Med Chem Lett

Johnson and Johnson Pharmaceutical Research and Development, Cranbury, NJ 08512, USA.

Published: June 2007

A number of RXR modulators with novel structural features were synthesized and screened in the functional assays. The synthesis and the structure-activity relationship within the series of compounds will be presented. Some in vivo data generated in the models for dyslipidemia and diabetes will also be presented.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.01.049DOI Listing

Publication Analysis

Top Keywords

will presented
8
dihydro-[1h]-quinolin-2-ones retinoid
4
retinoid receptor
4
receptor rxr
4
rxr agonists
4
agonists potential
4
potential treatment
4
treatment dyslipidemia
4
dyslipidemia number
4
number rxr
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!